DYNE THERAPEUTICS INC's ticker is DYN and the CUSIP is 26818M108. A total of 77 filers reported holding DYNE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,009,521 | -30.1% | 335,884 | -12.2% | 0.04% | -31.4% |
| Q2 2023 | $4,303,980 | -6.1% | 382,576 | -42.6% | 0.05% | -28.2% |
| Q2 2022 | $4,582,000 | -41.5% | 666,997 | -18.0% | 0.07% | -44.1% |
| Q1 2022 | $7,839,000 | +28.1% | 813,139 | +58.0% | 0.13% | +44.3% |
| Q4 2021 | $6,119,000 | +74.3% | 514,601 | +138.0% | 0.09% | +54.4% |
| Q3 2021 | $3,511,000 | -25.0% | 216,201 | -2.8% | 0.06% | -34.5% |
| Q2 2021 | $4,679,000 | -21.2% | 222,374 | -41.9% | 0.09% | -34.1% |
| Q1 2021 | $5,940,000 | -42.4% | 382,493 | -22.1% | 0.13% | -51.6% |
| Q4 2020 | $10,311,000 | +91.4% | 490,986 | +84.0% | 0.27% | +54.2% |
| Q3 2020 | $5,387,000 | – | 266,799 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 2,220,034 | $25,730,194 | 34.58% |
| MPM ASSET MANAGEMENT LLC | 4,951,303 | $57,385,602 | 24.01% |
| Atlas Venture Life Science Advisors, LLC | 9,869,483 | $114,387,308 | 13.78% |
| Logos Global Management LP | 2,150,000 | $24,918,500 | 2.92% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 641,068 | $7,417,157 | 2.29% |
| Deep Track Capital, LP | 2,684,200 | $31,109,878 | 1.31% |
| EcoR1 Capital, LLC | 2,322,384 | $26,916,431 | 0.82% |
| Vivo Capital, LLC | 577,642 | $6,695 | 0.77% |
| HighVista Strategies LLC | 102,431 | $1,187,175 | 0.70% |
| Monashee Investment Management LLC | 123,719 | $1,433,903 | 0.62% |